They found that children with systemic onset JIA (SoJIA) who did received anti-TNF therapy displayed over-expression levels of IFN-α-regulated genes in their blood leukocytes compared with patients without anti-TNF therapy. This evidence concerns the gene IFNA1 and systemic-onset juvenile idiopathic arthritis.